A suckling piglet model was used to study nutritional and pharmacologic means of 46 stimulating hepatic fatty acid 3-oxidation. Newborn pigs were fed milk diets containing either long-or medium-chain triglycerides (MCT). The long-chain control diet was 48 supplemented further with clofibric acid (0.5%) or isoproterenol (40 ppm 
Introduction 62
During the transition from intra-to extra-uterine life, survival of the young hinges on 64 up-regulation of the enzymes required to promote efficient utilization of fatty acids postpartum. While the primary energy source for the developing fetus is maternal glucose, 66 milk lipids become the principal source of energy for postnatal growth and development (13).
In support of the changing nutrient environment, many neonates including rats, rabbits, and 68 humans exhibit increased 3-oxidative capacity resulting in pronounced hyperketonemia (10,13,43). However, piglets do not show an appreciable accumulation of circulating ketone 70 bodies during the suckling period (1, 7, 38 ) and examination of fatty acid metabolism in cultured porcine hepatocytes demonstrates a propensity toward fatty acid re-esterification 72 with limited flux through the pathway of 3-oxidation (39). Why the piglet deviates from the accepted model of hepatic lipid metabolism in the young is not known. However, the 74 demand for energy after birth necessitates an understanding of the etiology of attenuated hepatic 3-oxidation in the piglet for improving neonatal survival, as 55-60% of the energy for 76 the newborn is derived from milk fatty acids (13).
It is well established that the carnitine palmitoyltransferase (CPT) system plays an 78 essential role in regulating fatty acid flux through the pathway of 3-oxidation (27). Most notably, CPT I and its regulation by malonyl-CoA governs the translocation of activated fatty 80 acids into the mitochondria for subsequent 3-oxidation. Data collected in neonatal pigs suggest that CPT I may contribute to the reduced rate of hepatic 3-oxidation noted in this 82 species (33, 35) . While CPT activity doubles between birth and 1 d of age, the activity measured at 1 d of age is equivalent to that measured at 24 d of age (5), inferring that activity 84 expeditiously increases postpartum before it plateaus after the first day of life. However, fatty acid oxidation in the 1 d old pig is only one third of the rate determined for the 24 d old 86 pig (5). This discrepancy between CPT activity and fatty acid oxidation may be explained by enhanced sensitivity of CPT I to malonyl-CoA. Studies examining tissue specific CPT 88 activity suggest that unlike most other mammals, hepatic CPT I in the neonatal pig is more sensitive to the inhibitory effects of malonyl-CoA (33). The high degree of sensitivity for 90 piglet hepatic CPT I is reflected in hepatic concentrations of malonyl-CoA, which are 94% lower than rat liver concentrations (11). However, piglet CPT I maintains its high degree of 92 sensitivity to malonyl-CoA under various physiological states (11,44), while in the rodent sensitivity to malonyl-CoA is decreased under physiological changes which elevate 94 circulating fatty acids (40).
As part of an ongoing research effort to understand the basis of low hepatic 3-96 oxidation in the young pig and the role of CPT I, the objectives of the study were to determine if dietary intervention with clofibrate, medium-chain triglycerides (MCT), or 98 isoproterenol would enhance hepatic 3-oxidation and CPT activity.
Clofibrate, a peroxisomal proliferator, has been shown to increase total (malonyl-CoA sensitive and in-100 sensitive) CPT activity in neonatal pigs, however, its effects on CPT I activity and mRNA abundance are not known. In addition, stimulation of peroxisomal oxidation which has been 102 shown to occur in piglets following clofibrate administration (50), provides an ancillary route for the oxidation of fatty acids, which may by-pass CPT I regulation of mitochondrial 3-104 oxidation. Secondly, MCT were fed to assess the response to a fatty acid energy source which is not reliant on CPT I for mitochondrial 3-oxidation (36). Thirdly, it was 106 hypothesized that the anti-lipogenic effects of isoproterenol (41) may reciprocally promote 3-oxidation. The study presented illustrates that hepatic 3-oxidation can be enhanced 108 concomitant with increased CPT I activity following clofibrate supplementation and is the first to report the effects of isoproterenol on hepatic fatty acid oxidation in neonatal pigs. 110
Research centered on improving 3-oxidation in the young pig may help to elucidate nutritional strategies to reduce neonatal morbidity and mortality in this species, while also 112 providing information on an animal model of interest to biomedical research.
114

Materials and Methods 114
Animals and diets. Procedures for this study were approved by the North Carolina State University Animal Care and Use committee. Piglets were obtained from North 116
Carolina State University Swine Education Unit within 24-48 h after birth (suckled). Piglets were individually housed in an environmentally controlled (30° C) facility and allotted by 118 gender and weight to one of four dietary treatments: 1) control milk replacer with soybean oil as the lipid source and formulated to 120 contain 21% fat, 32 % crude protein, and 34 % lactose, 2) control milk replacer supplemented with 0.5% (wt/wt) clofibrate, 122
3) control milk replacer with medium chain triglyceride (MCT) source replacing 95% of soybean oil, and 124 4) control milk replacer supplemented with 40 ppm isoproterenol.
Milk replacer was reconstituted with water to 15% (wt/vol) dry matter and fed via gravity 126 flow through a nipple. Milk replacer was mixed and replaced twice daily to maintain freshness, and dietary treatments were fed for 10 -12 d. Additional suckled piglets (24-48 h 128 of age) were euthanized at time of removal from dam to obtain data in the newborn. CPT I (liver and muscle isotypes), and acyl-CoA oxidase (ACO) ( Table 1 ). Primer pairs were selected for optimum annealing temperatures and negligible secondary structure. 210
Reagents and Chemicals. L-[N-Methyl-
Primers were purchased through Sigma-Genosys, Inc. and re-suspended in 1x Tris/EDTA.
The PCR aplicons were sequenced to verify primer accuracy/specificity. 212 The corrected variance was linearized and the standard error determined. 262
Statistical Analysis. Data were subjected to ANOVA using the general linear models 264 procedure of SAS (SAS Inc., Cary, NC) appropriate for a completely randomized design (CRD). Initial body weight was used as a covariate in analysis of growth parameters. Effects 266 of substrate (palmitate or glucose) oxidation were analyzed as a sub-plot within the CRD. A one-sided students t-test was used for determining significance in fold change of hepatic 268 ACO and LCPT I, and skeletal muscle MCPT I expression for clofibrate supplementation relative to control. 270
Results
At the end of the treatment period control, clofibrate, MCT, and isoproterenol 272 supplemented pigs weighed 5138g (± 135), 4743g (± 182), 4539g (± 197), and 4678g (± 193), respectively. In comparison to control pigs, MCT supplemented pigs weighed less (P = 274 0.02), while no differences were detected between control and clofibrate or isoproterenol treatments. Liver weights were 165g (± 7), 228g (± 10), 179g (± 10), and 142g (± 10) for 276 control, clofibrate, MCT, and isoproterenol supplemented pigs, respectively. Clofibrate supplementation increased liver weight by 38% (P < 0.0001). There was no difference in 278 liver weight following MCT or isoproterenol supplementation. The liver weight/body weight ratio was greater for clofibrate and MCT treatments (4.7 ± 0.17 and 4.1 ± 0.19, respectively) 280 than control pigs (3.3 ± 0.13), however, there was no difference between control and isoproterenol treatment (3.0 ± 0.18). 282
Total, mitochondrial, and peroxisomal first-cycle 3-oxidation rates of [1- (Table 3 ). However, in newborn pigs there was a 55% reduction in oxidative products (CO 2 plus ASP) when glucose was added to [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]-palmitate. 300
Differences in mean respiratory control ratios for isolated mitochondria were not detected, Values were 3 .0 for newborn, control, and clofibrate treated pigs; and 3.7 and 3.1 302 for MCT and isoproterenol treated pigs, respectively. Supplementation with clofibrate increased both malonyl-CoA sensitive (CPT I) and in-sensitive CPT activity by 64 and 304 105%, respectively. Supplementation with MCT or isoproterenol had no effect on CPT activity. For pigs receiving clofibrate supplementation, the relative abundance of liver CPT 306 I, skeletal muscle CPT I, and ACO mRNA also was determined. As assessed by real time pigs' ability to digest, absorb, and utilize medium chain fatty acids released from this energy source (36). When compared to long-chain fatty acids, the rate and extent of MCT utilization 396 was reported to be 3-and 4-fold greater, respectively (17). Greater oxidative flux of carbon has been measured in cultured porcine hepatocytes following MCT incubation (34); however, 398 we were unable to detect differences in palmitate oxidation nor CPT I activity following MCT feeding. Data collected from rodents also suggests that MCT feeding has no effect on 400 subsequent flux of long-chain fatty acids through 3-oxidation (40). Furthermore, final weight of pigs receiving MCT was less than control pigs. It has been reported that while the piglet 402 can utilize MCT growth is not improved (24).
It is interesting to note that MCT supplementation had no deleterious effects on 404 peroxisomal oxidation. Medium chain fatty acids are poor substrates for oxidation by the peroxisome, due to the lower affinity of acyl-CoA oxidase toward acyl substrates of eight or 406 fewer carbons (16). Furthermore, peroxisomal oxidative capacity is responsive to high-fat feeding of long-chain fatty acids (32). While suckling is important for establishment of 408 optimal peroxisomal 3-oxidative capacities (48,49), it appears that maintaining high rates of peroxisomal 3-oxidation is not dependent on a continual source of long chain fatty acids in 410 the young pig.
Effects of isoproterenol on palmitate oxidation. This study is the first to present the 412 effects of a 3-agonist on hepatic fatty acid oxidation in neonatal pigs. In-vitro studies in older pigs have shown a decrease in lipogenesis and an increase in lipolysis when porcine 414 adipose tissue explants were incubated with isoproterenol (a 31/32 agonist) (41). The effect on lipolysis also has been observed in vivo following isoproterenol infusion (30). 416
Furthermore, isoproterenol has increased circulating fatty acids 2-fold by 7 d of age in piglets (44). It was hypothesized that a putative effect of isoproterenol would be enhanced 3-418 oxidation as a consequence of increased circulating fatty acids resulting from isoproterenols known effects on lipolysis and lipogenesis. However, differences in rates of palmitate 420 oxidation or hepatic CPT I activity were not detected in this study.
First-pass metabolism by the liver may limit the bioavailability of isoproterenol when 422 fed as previously suggested (12). In rodents, isoproterenol stimulated lipolysis in isolated adipocytes, however, no effects on lipolysis were observed after the 3-agonist was fed (12). 
